# Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

> **NCT05202860** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Merete Haedersdal** · enrollment: 70 (actual)

## Conditions studied

- Actinic Keratoses
- Basal Cell Carcinoma
- Squamous Cell Carcinoma

## Interventions

- **BIOLOGICAL:** HPV Vaccine
- **BIOLOGICAL:** PLACEBO vaccine

## Key facts

- **NCT ID:** NCT05202860
- **Lead sponsor:** Merete Haedersdal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-09
- **Primary completion:** 2024-06-19
- **Final completion:** 2034-06-19
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05202860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05202860, "Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05202860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*